Inhibikase Therapeutics

/Inhibikase Therapeutics

We are a clinical stage pharmaceutical company developing therapeutics for Parkinson’s Disease, or PD, and related disorders that arise inside and outside of the brain.

Symbol

Last Closing Price
$5.96

Shares
8,000,000

Anticipated Date
June 16, 2021

Underwriters

This offering is no longer available

To view the prospectus for , or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange